BioGenome Therapeutics Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • BioGenome Therapeutics's estimated annual revenue is currently $1.4M per year.(i)
  • BioGenome Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • BioGenome Therapeutics has 9 Employees.(i)
  • BioGenome Therapeutics grew their employee count by -31% last year.

BioGenome Therapeutics's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.9M650%N/AN/A
#2
$0.3M20%N/AN/A
#3
$3.5M16-11%$18MN/A
#4
$1.1M7-22%N/AN/A
#5
$14.4M9327%N/AN/A
#6
$3.7M24-11%N/AN/A
#7
$9.6M623%N/AN/A
#8
$300M243-14%$53MN/A
#9
$3.1M2018%N/AN/A
#10
$0.8M5-17%N/AN/A
Add Company

What Is BioGenome Therapeutics?

BioGenome Therapeutics is an immunotherapy company developing methodologies to modulate genes and MiR pathways involved in cellular protection, repair and immune response.

keywords:N/A

N/A

Total Funding

9

Number of Employees

$1.4M

Revenue (est)

-31%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.9M90%N/A
#2
$0.7M9-10%N/A
#3
$0.7M90%N/A
#4
$0.7M9-25%N/A
#5
$1M10N/AN/A